Martynoside
Martynoside is a bioactive glycoside isolated from Rehmannia, exhibiting anti-estrogen, anticancer, and antioxidant activities. It functions via the ER pathway to upregulate IGFBP3 and has demonstrated cytotoxic and anti-metastatic effects in various in vitro research models.
Product Specifications
CAS Number
67884-12-2
Product Name Alternative
Martynoside, Estrogen receptor, Progestogen receptor, ROS
Field of Research
Metabolism Research
Purity
99.83% (May vary between batches)
Solubility
DMSO:16 mg/mL (24.52 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.06 mM)
Smiles
O ([C@H]1[C@H] (OC (/C=C/C2=CC (OC) =C (O) C=C2) =O) [C@@H] (CO) O[C@@H] (OCCC3=CC (O) =C (OC) C=C3) [C@@H]1O) [C@H]4[C@H] (O) [C@H] (O) [C@@H] (O) [C@H] (C) O4
Molecular Formula
C31H40O15
Molecular Weight
652.64
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
36931066 1.0 µg DNA
PLAGL2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details MBS1404040-01 0.5 mg (E-Coli)
Recombinant Rat Leucine-rich repeat-containing protein 4 (Lrrc4), partial
Sign In for Pricing
View Details MBS1404040-02 0.05 mg (Baculovirus)
Recombinant Rat Leucine-rich repeat-containing protein 4 (Lrrc4), partial
Sign In for Pricing
View Details MBS1404040-03 0.5 mg (Yeast)
Recombinant Rat Leucine-rich repeat-containing protein 4 (Lrrc4), partial
Sign In for Pricing
View Details MBS1404040-04 0.05 mg (Mammalian-Cell)
Recombinant Rat Leucine-rich repeat-containing protein 4 (Lrrc4), partial
Sign In for Pricing
View Details